|
2025
|
Invention
|
B cell compositions and methods of use. The present disclosure relates to a method of reducing ur... |
|
|
Invention
|
Methods for in vitro memory b cell differentiation and transduction with vsv-g pseudotyped viral ... |
|
|
Invention
|
Glp-1 expressing modified b cells for the treatment of metabolic disease. The present disclosure ... |
|
2024
|
Invention
|
Migratory modified differentiated b cells for cancer therapy. The present disclosure provides gen... |
|
|
Invention
|
Migratory modified differentiated b cells for cancer therapy |
|
|
Invention
|
Migratory modified differentiated b cells for cancer therapy.
The present disclosure provides ge... |
|
2022
|
Invention
|
B cells for in vivo delivery of therapeutic agents.
The present disclosure relates to geneticall... |
|
2021
|
Invention
|
Methods of administering genetically modified b cells for in vivo delivery of therapeutic agents.... |
|
2019
|
Invention
|
Chimeric antigen receptors specific to avb6 integrin and methods of use thereof to treat cancer. ... |
|
|
Invention
|
B cells genetically engineered to secrete follistatin and methods of using the same to treat foll... |
|
2018
|
Invention
|
B cells for in vivo delivery of therapeutic agents and dosages thereof.
The present invention re... |
|
|
Invention
|
B cells for in vivo delivery of therapeutic agents and dosages thereof. The present invention rel... |
|
|
Invention
|
Method to achieve extended expression of dna infused into liver. Materials and methods for treati... |
|
2015
|
Invention
|
B cells for in vivo delivery of therapeutic agents. The present disclosure relates to genetically... |
|
2013
|
Invention
|
Method to achieve extended expression of dna infused into liver.
Materials and methods for treat... |
|
2011
|
Invention
|
Vectors and methods for transducing b cells. The present disclosure provides compositions and met... |
|
2005
|
Invention
|
Integration-site directed vector systems. Some aspects of the application describe materials and ... |
